Notice2022-19656
Notice Pursuant to the National Cooperative Research and Production Act of 1993-Medical Technology Enterprise Consortium
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 13, 2022
Issuing agencies
Justice DepartmentAntitrust Division
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 176 (Tuesday, September 13, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 176 (Tuesday, September 13, 2022)]
[Notices]
[Pages 56089-56090]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-19656]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Antitrust Division
Notice Pursuant to the National Cooperative Research and
Production Act of 1993--Medical Technology Enterprise Consortium
Notice is hereby given that, on July 15, 2022, pursuant to Section
6(a) of the National Cooperative Research and Production Act of 1993,
15 U.S.C. 4301 et seq. (``the Act''), Medical Technology Enterprise
Consortium (``MTEC'') has filed written notifications simultaneously
with the Attorney General and the Federal Trade Commission disclosing
changes in its membership. The notifications were filed for the purpose
of extending the Act's provisions limiting the recovery of antitrust
plaintiffs to actual damages under specified circumstances.
Specifically, 1Focus LLC, Clearwater, FL; 4M Biotech, Ltd., Victoria,
CANADA; Action Medical Technologies LLC, Conshohocken, PA; Advanced
Biomimetic Sensors, Inc., Bethesda, MD; Aspen Stem Cell Institute LLC,
Basalt, CO; A-Tech LLC dba BlueHalo Labs, Albuquerque, NM; Biomeme,
Inc., Philadelphia, PA; BiotechPharma, Corp., Severna Park, MD; Bodies
Done Right, Mayfield Village, OH; Cellphire, Inc. dba Cellphire
Therapeutics, Inc., Rockville, MD; Collaborative Effort, Inc. dba RAIN
Incubator, Tacoma, WA; Cornell University, Ithaca, NY; DeltaStrac LLC,
New Windsor, MD; Eagle Global Scientific LLC, San Antonio, TX; Elephant
Ventures LLC, New York, NY; Gateway Biotechnology, Inc., St. Louis, MO;
HealthTech Connex, Surrey, CAN; Hememics Biotechnologies, Inc.,
Gaithersburg, MD; Human Systems Integration, Inc., East Walpole, MA;
IDION, Inc., Darien, CT; Independent Platform LLC, Salem, OR;
International AIDS Vaccine Initiative, New York, NY; Laulima Government
Solutions, Orlando, FL; Link to Learn, Denver, CO; Mainstream
Engineering Corp., Rockledge, FL; MDB, Inc., Washington, DC; MedCu
Technologies Ltd., Herzliya, ISR; Nanobionic Technologies Limited,
Nicosia, CYP; Neunos ZRt, Szeged, HUN; Neuro11 Technologies, Inc.,
Cambridge, MA; NeuroStat Analytical Solutions, Great Falls, VA;
Neursantys, Inc., Chicago, IL; OARK ApS, Hammel, DNK; Omnica Corp.,
Irvine, CA; Oregon Biomedical Engineering Institute, Inc., Wilsonville,
OR; Palantir USG, Inc., Palo Alto, CA; PathoGene, Inc., Monrovia, CA;
Pixel and Timber LLC, Cincinnati, OH; Polaris Sensor Technologies,
Inc., Huntsville, AL; Powerbuilding Holdings Corp., Staten Island, NY;
Proxima Clinical Research, Houston, TX; Puerto Rico Science, Technology
and Research Trust, San Juan, PRI; Qidni Labs, Inc., Buffalo, NY;
Resonantia Diagnostics, New York, NY; Resusitech, Inc., Menlo Park, CA;
Rx Bandz, Austin, TX; Senseye, Inc., Austin, TX; Shock Therapeutics
Biotechnologies, Inc., Baltimore, MD; Siemens Medical Solutions USA,
Inc., Princeton, NJ; Singularity Scitech LLC, Bronxville, NY;
SmartHealth Catalyzer, Inc., Riverwoods, IL; Social Science Innovations
Corp., New York, NY; Sonogen Medical, Inc., Chevy Chase, MD; Sonosa
Medical, Inc., Baltimore, MD; Spectral MD, Inc., Dallas, TX;
TensionSquare LLC, Port Charlotte, FL; Terasaki Institute for
Biomedical Innovation, Los Angeles, CA; The Mullings Group, Delray
Beach, FL; TMG360 Media, Delray Beach, FL; Triple Ring Technologies,
Newark, CA; TroutHouseTech LLC, Arlington, VA; University of Alaska
Fairbanks, Fairbanks, AK; University of Notre Dame, Notre Dame, IN;
UTL, Inc., Carlsbad, CA; Vadum, Inc., Raleigh, NC; Virion Therapeutics
LLC, Newark, DE; have been added as parties to this venture.
Also, Abfero Pharmaceuticals, Inc., Boston, MA; Aerpio
Pharmaceuticals, Cincinnati, OH; AirSupport LLC, Baltimore, MD;
Alertgy, Inc., Melbourne, FL; Aptive Resources LLC, Alexandria, VA;
Arteriocyte, Inc. dba Compass Biomedical, Hopkinton, MA; Ashvattha
Therapeutics, Inc., Redwood City, CA; Asymmetric Technologies LLC,
Columbus, OH; Bettermeant, Inc., Berkeley, CA; Boa Biomedical, Inc.,
Cambridge, MA; Board of Trustees of
[[Page 56090]]
the Leland Stanford Junior University, Palo Alto, CA; Carnegie Mellon
University, Pittsburg, PA; Celerens LLC, Clarksville, MD; Data
Intelligence Technologies, Inc., Arlington, VA; DataRobot, Inc.,
Boston, MA; Dawson Technical, Inc., Irvine, CA; Diagnoss, Inc., Pomona,
CA; Diomics Corp., Murrieta, CA; DocBox, Inc., Waltham, MA; Embody LLC,
Norfolk, VA; Evidence Based Psychology LLC dba Susan David, Newton, MA;
FirstString Research, Inc., Mt. Pleasant, SC; Five Vital Signs,
Houston, TX; FloTBI, Inc., Cleveland, OH; Friedman Research Corp.,
Austin, TX; Full Spectrum Omega, Inc., Los Angeles, CA; Fusion
Consulting, Inc., Farmers Branch, TX; General Biologics, Inc.,
Cambridge, MA; Global Institute of Stem Cell Therapy and Research,
Inc., San Diego, CA; H&H Medical Corp., Williamsburg, VA; Healing Our
Heroes Foundation dba The Mission After, Del Mar, CA; Hybrid Plastics,
Inc., Hattiesburg, MS; Iacta Pharmaceuticals, Inc., Irvine, CA;
Intelligent Automation, Inc., Rockville, MD; IRegained, Inc., Sudbury,
CAN; KMASS Solutions, El Paso, TX; Kopis Mobile LLC, Flowood, MS; L-3
Applied Technologies, Inc., San Diego, CA; Levi Diagnostics, Inc., Fall
River, MA; LexisNexis Risk Solutions, Inc., Washington, DC; Life365
Inc., Scottsdale, AZ; luxML LLC, San Antonio, TX; MadApparel Ind. dba
Athos, Redwood City, CA; ManTech Advanced Systems International, Inc.,
Herndon, VA; Medical Center of the Americas Foundation, El Paso, TX;
Medical Informatics Corp., Houston, TX; MEDX SpA, Regi[oacute]n
metropolitana, Santiago de Chile, CHL; Moleculin Biotech, Inc.,
Houston, TX; Movement Rx Physical Therapy, P.C., San Diego, CA;
NanoOxygenic LLC, Dallas, TX; NeurAegis, Inc., Southborough, MA;
Neuronasal, Inc., Wexford, PA; Nexsys Electronics Inc. dba Medweb, San
Francisco, CA; Nostromo LLC, Kennebunk, ME; Novel Technologies Holdings
Limited, Manchester, NH; Noveome Biotherapeutics, Inc., Pittsburg, PA;
Obatala Sciences, Inc., New Orleans, LA; Odin Technologies, Charlotte,
NC; OLGS, Inc., Imperial, PA; Oregon Health & Science University,
Portland, OR; Osteal Therapeutics, Inc., San Clemente, CA; Overseas
Strategic Consulting, Ltd, Philadelphia, PA; Oxygenium, Inc., Great
Neck, NY; Panakeia LLC, Newport News, VA; PercuSense, Inc., Valencia,
CA; Platelet BioGenesis, Inc., Cambridge, MA; Presidio Government
Solutions LLC, Reston, VA; Programs Management Analytics &
Technologies, Inc., Norfolk, VA; Q30 Sports Science LLC, Westport, CT;
QuesGen Systems, Burlingame, CA; Renaissance Biotech LLC, Malibu, CA;
Resolys Bio, Inc., Delanson, NY; ServiceNow, Inc., Vienna, VA;
SpherIngenics, Inc., Richmond, VA; StataDX, Inc., Cambridge, MA;
Synthesis Technologies, Inc., Pasadena, CA; Tanner Research, Inc.,
Duarte, CA; TeleCommunication Systems, Inc., Annapolis, MD; Through The
Cords LLC, Salt Lake City, UT; Traumatic Direct Transfusion Devices
LLC, Raleigh, NC; Tunnell Consulting, Inc., Bethesda, MD; University of
Connecticut, Storrs, CT; University of Kansas Medical Center Research
Institute, Inc., Kansas City, KS; ViiNetwork, Inc ViiMed, Washington,
DC; Wearable Artificial Organs, Inc., Beverly Hills, CA; WearOptimo,
Woolloongabba, Queensland, AUS; Western Michigan University Homer
Stryker M.D. School of Medicine, Kalamazoo, MI; XSurgical, Inc.,
Ipswich, MA; Zansors LLC, Arlington, VA; have withdrawn as parties to
this venture.
No other changes have been made in either the membership or planned
activity of the group research project. Membership in this group
research project remains open, and MTEC intends to file additional
written notifications disclosing all changes in membership.
On May 9, 2014, MTEC filed its original notification pursuant to
Section 6(a) of the Act. The Department of Justice published a notice
in the Federal Register pursuant to Section 6(b) of the Act on June 9,
2014 (79 FR 32999).
The last notification was filed with the Department on April 14,
2022. A notice was published in the Federal Register pursuant to
Section 6(b) of the Act on May 13, 2022 (87 FR 29382).
Suzanne Morris,
Chief, Premerger and Division Statistics, Antitrust Division.
[FR Doc. 2022-19656 Filed 9-12-22; 8:45 am]
BILLING CODE P
</pre></body>
</html>Indexed from Federal Register on September 13, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.